Alexandria Real Estate Equities (ARE) has been having a turbulent ride with various factors affecting its performance. They have had a weaker outlook for 2025 due to sector headwinds and its price target has been decreased by 16.20% to 81.99. The stock hit a 52-week low at $49.28. Despite the setbacks analysts remain divided on their recommendations. On one hand, some believe it's worth revisiting after a 50% drop, potentially making it attractive for retirement portfolios. On the other hand, triggering concerns are its lower than expected Q3 earnings and revenue estimates, instigating a wave of price reductions. Alexandria's prospects in outperforming foreign stocks and its potential for raising dividends are under scrutiny. Despite these obstacles, there are still supporters who see value in buying ARE stock amidst peak pessimism. A strategic partnership with Lilly Gateway Labs is also on the horizon, which might provide a positive boost. However, the overall climate remains uncertain as Alexandria continues to navigate through numerous challenges.
Alexandria Real Estate Equities ARE News Analytics from Mon, 14 Jul 2025 07:00:00 GMT to Sat, 22 Nov 2025 11:35:06 GMT -
Rating -5
- Innovation -2
- Information 3
- Rumor -4
